Question
Is fluvoxamine effective in preventing hospitalizations in high-risk adults with COVID-19?
Conclusion
In this study, compared with placebo, fluvoxamine decreased hospitalizations in high-risk symptomatic adults with COVID-19.
Recent Posts
- Is In-person and remote physical therapy are equally effective for Chronic Knee Pain?
- The risk of breast cancer overdiagnosis is high for older women
- Severe hypocalcemia with denosumab therapy in dialysis-treated patients
- Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR)
- No increased risk of esophageal cancer with nonerosive gastroesophageal reflux